Articles by James Calloway
Moderna Shares Rise on Q4 Beat, Flu Vaccine Faces FDA Hurdle
Moderna shares advanced roughly 5% late Friday after reporting better-than-expected Q4 revenue. The company reaffirmed its 2026 growth targets despite an FDA setback for its seasonal flu vaccine.
McDonald's Shares Dip After CEO Files to Sell $8.5M in Stock
McDonald's shares declined in extended trading following a CEO stock sale filing, even as the company posted robust quarterly results and received a Buy rating upgrade from Argus.
Spotify Shares Recover After Hours Following Steep Prior-Day Decline
Spotify shares gained 2.8% in extended trading Friday, recovering from an 8.5% drop. The company reported 751 million monthly active users and provided upbeat Q1 profit guidance.
Howmet Aerospace Surges on Strong Outlook, Analyst Upgrades
Howmet Aerospace shares gained over 2% following an upbeat earnings forecast and strong quarterly results, driven by record backlog and robust gas turbine demand.
T-Mobile Shares Climb on Buyback Boost and European Debt Offering
T-Mobile shares advanced as the company doubled its Q1 buyback target to $5 billion and priced a €2.5 billion European bond offering. The telecom also reported strong postpaid phone net additions.
Ex-CEO Gets 20 Years for $200M Bitcoin Ponzi Scheme
Former Praetorian Group International CEO Ramil Palafox received a 20-year prison sentence for orchestrating a $200 million Bitcoin Ponzi scheme that defrauded investors worldwide.
Expedia Shares Drop on Cautious 2026 Margin Outlook
Expedia shares declined nearly 5% as investors focused on the company's tempered 2026 profit margin guidance, overshadowing solid fourth-quarter results.
Roku Shares Surge on Upbeat 2026 Financial Targets
Roku shares gained sharply after the streaming platform provider issued stronger-than-expected financial targets for 2026, highlighting growth in its advertising and platform business.
Lilly Builds $1.5B Obesity Pill Inventory Ahead of Key FDA Decision
Eli Lilly shares gained as the pharmaceutical giant disclosed a $1.5 billion inventory build for its experimental oral obesity treatment ahead of an anticipated FDA decision in April.
Shopify Rebounds on Buyback News, But Margin Concerns Linger
Shopify shares recovered some ground Friday, rising 1.6% after steep declines, as the company announced the start date for its $2 billion share repurchase program. However, investor focus remains on its cash-flow margin outlook following heavy AI and expansion investments.
Walmart Gains as KeyBanc Boosts Target Ahead of Q4 Report
Walmart shares advanced Friday following a price target increase from KeyBanc Capital Markets. The retailer is set to report fourth-quarter results on February 19.